TY  - JOUR
AU  - Temkin, Elizabeth
AU  - Torre-Cisneros, Julian
AU  - Beovic, Bojana
AU  - Benito, Natividad
AU  - Giannella, Maddalena
AU  - Gilarranz, Raul
AU  - Jeremiah, Cameron
AU  - Loeches, Belen
AU  - Machuca, Isabel
AU  - Jose Jimenez-Martin, Maria
AU  - Antonio Martinez, Jose
AU  - Mora-Rillo, Marta
AU  - Navas, Enrique
AU  - Osthoff, Michael
AU  - Carlos Pozo, Juan
AU  - Ramos Ramos, Juan Carlos
AU  - Rodriguez, Marina
AU  - Sanchez-Garcia, Miguel
AU  - Viale, Pierluigi
AU  - Wolff, Michel
AU  - Carmeli, Yehuda
PY  - 2016
DO  - 10.1128/AAC.01964-16
SN  - 0066-4804
UR  - http://hdl.handle.net/10668/19007
T2  - Antimicrobial agents and chemotherapy
AB  - Ceftazidime-avibactam (CAZ-AVI) is a recently approved beta-lactam-beta-lactamase inhibitor combination with the potential to treat serious infections caused by carbapenem-resistant organisms. Few patients with such infections were included in the...
LA  - en
PB  - American Society for Microbiology
KW  - Carbapenem resistance
KW  - Case series
KW  - Ceftazidime-avibactam
KW  - Blood-stream infections
KW  - Klebsiella-pneumoniae
KW  - Plus metronidazole
KW  - Colistin-resistant
KW  - Double-blind
KW  - Enterobacteriaceae
KW  - Bacteremia
KW  - Efficacy
KW  - Safety
KW  - Combination
TI  - Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
TY  - research article
VL  - 61
ER  -